Evidence map›Paper›PMID 41076603›Full record

ReviewWorld journal of urology2025

Same day discharge after robot assisted partial nephrectomy.

Ronny Baqain, Laith Baqain, Sohrab Ali, Simone Crivellaro, David Lee, Ryan W Dobbs, Mohammad Shahait

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Ronny BaqainUniversity of Manchester, Manchester, UK.
Laith BaqainDivision of Gastroenterology and Hepatology, New York-Presbyterian Weill Cornell Medical Center, New York, NY, USA.
Sohrab AliDepartment of Urology, University of California, Irvine, USA.
Simone CrivellaroDepartment of Urology, Robotic Urology, UIC Urology at Mount Sinai Hospital, University of Illinois at Chicago, College of Medicine, University of Illinois Hospital Health Sciences System, Chicago, USA.
David LeeDepartment of Urology, University of California, Irvine, USA.
Ryan W DobbsDepartment of Urology, Cook County Health & Hospitals System, Chicago, USA.
Mohammad ShahaitDepartment of Urology, University of California, Irvine, USA. mshahait@hs.uci.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePartial nephrectomy (PN) is the standard treatment for small renal masses, offering effective cancer control while preserving renal function. The adoption of robotic assisted partial nephrectomy (RAPN) has improved perioperative outcomes, and there is a growing interest in same-day discharge as a strategy to enhance recovery, reduce healthcare costs, and achieve more favourable postoperative outcomes. This review evaluates the current evidence surrounding SDD following RAPN, focusing on perioperative outcomes, patient selection, and evolving surgical practices.

methodsA comprehensive literature search identified seven studies reporting outcomes of SDD RAPN, including a total of 485 patients. The findings suggest that SDD can be implemented safely, with complication, readmission, and emergency department visits similar to those observed in inpatient cohorts. Enhanced Recovery After Surgery (ERAS) protocols and minimally invasive surgical techniques such as single-port and retroperitoneal approaches, play an important role in facilitating early discharge by reducing postoperative pain, enhancing recovery, and shortening hospital stays.

resultsEffective implementation of SDD relies on appropriate patient selection, surgeon experience, and institutional infrastructure. Future directions include refining discharge criteria, standardizing ERAS protocols, and incorporating postoperative tools such as telemedicine and wearable technologies.

conclusionSDD after RAPN is both feasible and safe in selected patients. Broader adoption will depend on the development of standardized pathways, robust patient selection strategies, and additional research to validate outcomes across clinical settings.

Indexed as

Ambulatory Surgical ProceduresKidney NeoplasmsNephrectomyPatient DischargeRobotic Surgical ProceduresEnhanced Recovery After SurgeryHumansAmbulatory surgical proceduresKidney tumorsMinimally invasive surgical proceduresNephron sparing surgeryPartial nephrectomyRenal carcinomaRobotics

Identifiers

PMID41076603
PMCPMC12515744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.